Clinical Trials Lilly’s tirzepatide leads to body weight reductions in type 2 diabetes trial 05 Mar 2021
NeuroVia starts Phase l/ll trial of NV1205 for CCALD NeuroVia has commenced a Phase l/ll clinical trial of NV1205 for the treatment of patients... 27th July 2018
Clinical Trials Lilly’s tirzepatide leads to body weight reductions in type 2 diabetes trial 05 Mar 2021
Clinical Trials Dicerna and Roche start Phase II trial of GalXC RNAi candidate in hepatitis B 05 Mar 2021
Clinical Trials Marker Therapeutics treats first subject in acute myeloid leukaemia trial 04 Mar 2021